author-photo

Nene N. Kalu

Johns Hopkins University

14

Papers

93

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Abstract 4646: Pharmacogenomic screen identifiesKMT2Dmutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1560: Differential sensitivity analysis for resistant malignancies (DISARM), a novel approach for drug screen analysis, identifies common candidate drugs across platinum-resistant cancer types

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Do CDK4/6 inhibitors have potential as targeted therapeutics for squamous cell cancers?

2017 Expert Opinion on Investigational Drugs
- Nene N. Kalu
- Faye M. Johnson
Show All
- Source
- Cite
- Save
Citations (9)
Nelfinavir Inhibits Maturation and Export of Herpes Simplex Virus 1

2014 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (21)
Abstract C19: Nelfinavir-induced autophagy and cell death as potential anticancer therapy for KSHV-associated lymphomas.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 558: Bortezomib induction of the unfolded protein response mediates Epstein-Barr virus lytic activation but is separable from bortezomib-induced cytotoxicity

2012 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
ER stress activates lytic gene expression in KSHV-associated tumor cell lines

2012 Infectious Agents and Cancer
Show All
- Source
- Cite
- Save
Citations (2)
C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression

2010 Infectious Agents and Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Epstein-Barr Virus and Kaposi9s Sarcoma Herpesvirus Lytic Cycle Induction with Bortezomib Is a Response to ER Stress

2010 Blood
Show All
- Source
- Cite
- Save
Citations (2)